A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this research study is to look at how your tumor responds to treatment with a combination of three drugs: letrozole, trastuzumab, and palbociclib. We will also be looking at the side effects that are associated with this combination of drugs.
Description
This study will look at how subject's tumor responds to treatment with a combination of three drugs: letrozole, trastuzumab, and palbociclib. Researchers will also be looking at the side effects that are associated with this combination of drugs.
Details
| Condition | breast cancer |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX8513 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.